Martine A Rothblatt United Therapeutics Corp (UTHR) insider trading activity

Martine A Rothblatt is Chairperson & CEO of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 130 shares of UTHR, which is worth approximately $47,333. The most recent transaction as insider was on Apr 22, 2024, when has been sold 3,600 shares (Common Stock) at a price of $129.49 per share, resulting in proceeds of $466,164. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130

0% 3M change

0% 12M change

Total Value Held $47,333

MARTINE A ROTHBLATT Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 22 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 19 2024	SELL Open market or private sale	$852,984 $236.94 p/Share	3,600 Reduced 96.51%	130 Common Stock
Apr 19 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 18 2024	SELL Open market or private sale	$855,792 $237.72 p/Share	3,600 Reduced 96.51%	130 Common Stock
Apr 18 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 17 2024	SELL Open market or private sale	$845,964 $234.99 p/Share	3,600 Reduced 96.51%	130 Common Stock
Apr 17 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 16 2024	SELL Open market or private sale	$836,352 $232.32 p/Share	3,600 Reduced 96.51%	130 Common Stock
Apr 16 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 15 2024	SELL Open market or private sale	$847,980 $235.55 p/Share	3,600 Reduced 96.51%	130 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 12 2024	SELL Open market or private sale	$849,204 $235.89 p/Share	3,600 Reduced 96.51%	130 Common Stock
Apr 12 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 11 2024	SELL Open market or private sale	$861,336 $239.26 p/Share	3,600 Reduced 96.51%	130 Common Stock
Apr 11 2024	BUY Exercise of conversion of derivative security	$466,164 $129.49 p/Share	3,600 Added 49.11%	3,730 Common Stock
Apr 10 2024	SELL Open market or private sale	$3,254,454 $235.83 p/Share	13,800 Reduced 99.07%	130 Common Stock
Apr 10 2024	BUY Exercise of conversion of derivative security	$1,786,962 $129.49 p/Share	13,800 Added 49.77%	13,930 Common Stock
Apr 09 2024	SELL Open market or private sale	$3,556,950 $237.13 p/Share	15,000 Reduced 99.14%	130 Common Stock
Apr 09 2024	BUY Exercise of conversion of derivative security	$1,942,350 $129.49 p/Share	15,000 Added 49.78%	15,130 Common Stock
Apr 08 2024	SELL Open market or private sale	$1,198,157 $236.79 p/Share	5,060 Reduced 97.5%	130 Common Stock
Apr 08 2024	BUY Exercise of conversion of derivative security	$655,219 $129.49 p/Share	5,060 Added 49.37%	5,190 Common Stock
Apr 05 2024	SELL Open market or private sale	$3,513,450 $234.23 p/Share	15,000 Reduced 99.14%	130 Common Stock
Apr 05 2024	BUY Exercise of conversion of derivative security	$1,942,350 $129.49 p/Share	15,000 Added 49.78%	15,130 Common Stock
Apr 04 2024	SELL Open market or private sale	$3,490,350 $232.69 p/Share	15,000 Reduced 99.14%	130 Common Stock
Apr 04 2024	BUY Exercise of conversion of derivative security	$1,942,350 $129.49 p/Share	15,000 Added 49.78%	15,130 Common Stock

MAR

Martine A Rothblatt

Chairperson & CEO

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account